公司概覽
業務類別 Biotechnology
業務概覽 Telix is a developer of radiopharmaceuticals. Radiopharmaceuticals are specialized drugs containing radioactive isotopes, which are used in both diagnosing and treating cancer. At low doses, these drugs bind to a specific cancer cell and can be visualized through PET imaging. With high doses, they can deliver targeted treatment. Telix has a pipeline of both diagnostics and therapeutics in development. Its pipeline is focused on urologic oncology (prostate, kidney and bladder), neuro-oncology (glioma), musculoskeletal oncology and hematology. Currently, most of the firm's revenue comes from its Illuccix prostate cancer imaging/diagnostic agent.
公司地址 55 Flemington Road, Level 4, North Melbourne, Melbourne, VIC, AUS, 3051
電話號碼 +61 390933855
傳真號碼 --
公司網頁 https://www.telixpharma.com
員工數量 1184
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Dr. Christian Behrenbruch, M.B.A.,PhD Director, Managing Director and Group Chief Executive Officer 美元 556.72K 20/02/2026
Mr. Darren Patti, Pharm.D. Group Chief Operating Officer 美元 381.88K 20/02/2026
Mr. Darren Smith, M.B.A. Group Chief Financial Officer 美元 488.99K 20/02/2026
Mr. David Cade, M.B.A.,M.D. Group Chief Medical Officer 美元 368.90K 20/02/2026
Mr. Kevin Richardson Chief Executive Officer, Telix Precision Medicine -- 20/02/2026
Dr. Mary Jessel Group Chief of Clinical Affairs -- 20/02/2026
Mr. Richard Valeix Chief Executive Officer, Telix Therapeutics 美元 255.26K 20/02/2026
Ms. Lena Moran-Adams Group General Counsel -- 20/02/2026
Ms. Meredith Crowe Senior Vice President, People and Culture -- 20/02/2026
Ms. Genevieve Ryan Company Secretary -- 20/02/2026
Mr. Raphael Ortiz Chief Executive Officer, Telix International -- 20/02/2026
 
董事會成員
董事會 職務 更新日期
Ms. Marie McDonald Independent Director 20/02/2026
Dr. Christian Behrenbruch, M.B.A.,PhD Director, Managing Director and Group Chief Executive Officer 20/02/2026
Dr. Mark Nelson, M.Phil,PhD Interim Chairman of the board 20/02/2026
Ms. Jann Skinner, B.Com,F.C.A. Independent Director 20/02/2026
 
所屬ETF (更新日期: 07/11/2026 03:57)
代號 名稱 佔比% ▼ 持有日期
APIEActivePassive International Equity ETF0.003%30/10/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.